Gareth Maher‐Edwards

Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease

Gareth Maher‐Edwards, Marina Zvartau‐Hind, Andrea Hunter et al. · Current Alzheimer Research · 2010 · 113 citations

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study

Gareth Maher‐Edwards, Ruth Dixon, Jackie Hunter et al. · International Journal of Geriatric Psychiatry · 2010 · 104 citations

Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin

Lina Keutzer, Huifang You, Ali Farnoud et al. · Pharmaceutics · 2022 · 76 citations · Full text

A 24‐week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease

Gareth Maher‐Edwards, Jeni De'Ath, Carly Barnett et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2015 · 50 citations · Full text

Two randomized controlled trials of SB742457 in mild‐to‐moderate Alzheimer's disease

Gareth Maher‐Edwards, Carolyn Watson, John A. Ascher et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2015 · 45 citations · Full text